AB
Arbutus Biopharma Corp
ABUS · NASDAQ
$5.01 -0.60% (-$0.03)
1M -3.85%
Market Cap $987.7M
P/E Ratio 6.45x
Div. Yield -
ROE 90.98%
Bulios Fair Price
$3.53
29.5% downside
Trenutna cena
$5.01
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica ABUS trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
82 /100
Cheap EV/EBITDA 6.35x
P/S 5.44x
P/B 3.82x
Growth
0 /100
Declining Book val. growth 17.60%
Rev. growth 28.80%
FCF growth N/A
Profitability
70 /100
Strong Net margin 84.23%
Op. margin 81.01%
FCF margin 13.55%
Quality
93 /100
Excellent ROE 90.98%
ROA 55.85%
Asset turnover 0.66x
Debt
100 /100
Low Current ratio 81.42x
Int. coverage 2,014.87x
Net debt/EBITDA -0.10x
Stability
47 /100
Moderate Rev. volatility 108.70%
EPS volatility 27.12%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o ABUS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Lindsay Androski
Employees
19
Headquarters
Warminster
Prihajajoči dogodki
16 NOV.
Earnings
Upcoming earnings report